Literature DB >> 15989706

Activity of gallium nitrate in refractory peripheral T-cell lymphoma.

ZuoMing Huang1, Beth Higgins, Francine Foss.   

Abstract

Peripheral T-cell lymphomas (PTCLs) are post-thymic malignancies characterized by an aggressive clinical course and an inferior outcome with standard therapies. The authors report significant clinical activity of infusional gallium nitrate in a patient with stage IV PTCL disease refractory to chemotherapy.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15989706     DOI： 10.3816/clm.2005.n.026

Source DB:  PubMed          Journal:  Clin Lymphoma        ISSN： 1526-9655


  3 in total

1.  Gallium maltolate inhibits human cutaneous T-cell lymphoma tumor development in mice.

Authors:  Xuesong Wu; Timothy W Wang; George M Lessmann; Jamal Saleh; Xiping Liu; Christopher R Chitambar; Sam T Hwang
Journal:  J Invest Dermatol       Date:  2014-11-05       Impact factor: 8.551

Review 2.  Medical applications and toxicities of gallium compounds.

Authors:  Christopher R Chitambar
Journal:  Int J Environ Res Public Health       Date:  2010-05-10       Impact factor: 3.390

3.  Role of oxidative stress in the induction of metallothionein-2A and heme oxygenase-1 gene expression by the antineoplastic agent gallium nitrate in human lymphoma cells.

Authors:  Meiying Yang; Christopher R Chitambar
Journal:  Free Radic Biol Med       Date:  2008-06-14       Impact factor: 7.376
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.